Crown Bioscience Germany GmbH

Crown Bioscience, Inc. is a Preclinical CRO with expertise in the disease areas of Oncology and Metabolic Disease.

We are known for the breadth and quality of our in vitro and in vivo models, as well as for our ability to help clients quantify the real efficacy and pharmacological profile of their candidate before they move into the clinic. As drug discovery continues to rapidly evolve, there is a growing need to screen candidates earlier and with more patient-relevant models, which more closely reflect the situation in the clinic and therefore help improve the selection of drug candidates. Our unique collection of ready-to-run, well-validated in vitro and in vivo models, expertise in model development, comprehensive drug discovery platforms, and global capacity enable us to deliver the results you need, today.

Our team of experts includes highly trained PhD and MS scientists from around the world. Most Crown Bioscience scientists have a deep understanding of the pharmaceutical industry having lead major departments within the top US pharmaceutical R&D and preclinical programs. At Crown Bioscience, our scientists engage with you in the design and execution of your preclinical drug development program using our AAALAC approved animal facilities, proprietary animal models, and in vivo surgical expertise. We pride ourselves on the quality of our work and completing projects swiftly and cost-effectively.

We are headquartered in the heart of Silicon Valley, with wholly-owned research facilities in Kannapolis (USA), San Diego (USA), Beijing (China), Taicang near Shanghai (China) and Loughborough (UK). Our state-of-the-art animal vivaria cover over 150,000 square feet and are AAALAC accredited. A truly global operation providing local service and support for your drug discovery needs.